DXCM:NASDAQ
DexCom Inc
$85.98
arrow_downward
-0.07%(-0.060) 1D
$85.98
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DXCM...
Open
$86.10
High
$86.61
Low
$85.43
Mkt. cap
32.45B
Avg. vol.
3.98M
Volume
2.59M
P/E ratio
34.11
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.48
Shares outstanding
377.36M
No. of employees
11K
Open
$86.10
High
$86.61
Low
$85.43
Mkt. cap
32.45B
Avg. vol.
3.98M
Volume
2.59M
P/E ratio
34.11
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.48
Shares outstanding
377.36M
No. of employees
11K
News stories
From web sources and news partners
TradingView
·
34 minutes ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
BBN Times
·
59 minutes ago
S&P 500 Rises to 7,690.73 as Tech and AI Stocks Rebound From Worst Week Since June Amid US-Iran Negotiations
Investor's Business Daily
·
1 hour ago
Dow Jones Futures: AMD, Nvidia Lead AI Trade Higher; Meta, Netflix, SpaceX, Tesla Earnings On Deck
Investing.com
·
2 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com
Analyst ratings
Based on 20 analysts giving stock ratings to DXCM in the past 3 months
Strong buy
Buy
19
Hold
1
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for DXCM in the last 3 months.
Highest
Current $85.98
$115.00 (+33.75%)
Average
$96.39 (+12.11%)
Lowest
$82.00 (-4.63%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Joanne Wuensch Citi | Buy | Maintained | $105.00 | +22.1% | 10/14/2026 |
Larry Biegelsen Wells Fargo | Buy | Maintained | $90.00 | +4.7% | 10/14/2026 |
Anthony Petrone Mizuho Securities | Buy | Reiterated | $100.00 | +16.3% | 10/13/2026 |
Ryan Zimmerman BTIG | Buy | Maintained | $96.00 | +11.7% | 10/12/2026 |
Marie Thibault BTIG | Buy | Maintained | $96.00 | +11.7% | 10/12/2026 |
Christopher Pasquale Barclays | Buy | Initiated | $115.00 | +33.8% | 10/07/2026 |
Matt Miksic Barclays | Buy | Maintained | $115.00 | +33.8% | 10/07/2026 |
Kendall Au RBC Capital | Buy | Maintained | $105.00 | +22.1% | 10/01/2026 |
Shagun Singh Chadha RBC Capital | Buy | Maintained | $105.00 | +22.1% | 10/01/2026 |
Richard Newitter Truist Financial | Buy | Maintained | $102.00 | +18.6% | 09/23/2026 |
Josh Jennings TD Cowen | Buy | Maintained | $95.00 | +10.5% | 09/18/2026 |
Robbie Marcus J.P. Morgan | Hold | Maintained | $82.00 | -4.6% | 08/04/2026 |
Steven Silver Argus Research | Buy | Maintained | $96.00 | +11.7% | 08/03/2026 |
William Plovanic Canaccord Genuity | Buy | Reiterated | $90.00 | +4.7% | 08/03/2026 |
Travis Steed Bank of America Securities | Buy | Maintained | - | - | 07/31/2026 |
Steven Lichtman William Blair | Buy | Maintained | - | - | 07/31/2026 |
Kieran Ryan Deutsche Bank | Buy | Reiterated | $92.00 | +7% | 07/31/2026 |
Jayson Bedford Raymond James | Buy | Maintained | $94.00 | +9.3% | 07/31/2026 |
Bruce Jackson StoneX | Buy | Maintained | $82.00 | -4.6% | 07/31/2026 |
Matthew O'Brien Piper Sandler | Buy | Reiterated | $95.00 | +10.5% | 07/31/2026 |
Jeff Johnson Robert W. Baird | Buy | Maintained | $105.00 | +22.1% | 07/31/2026 |
Jonathan Block Stifel Nicolaus | Buy | Reiterated | $95.00 | +10.5% | 07/31/2026 |
Danielle Antalffy UBS | Buy | Maintained | $96.00 | +11.7% | 07/28/2026 |
Patrick Wood UBS | Buy | Maintained | $96.00 | +11.7% | 07/28/2026 |
Unknown Analyst Deutsche Bank | Buy | Initiated | $86.00 | +0% | 06/25/2026 |
David Roman Goldman Sachs | Buy | Maintained | $80.00 | -7% | 05/15/2026 |
Unknown Analyst Stifel Nicolaus | Buy | Maintained | $85.00 | -1.1% | 05/15/2026 |
Lee Hambright Bernstein | Buy | Maintained | $77.00 | -10.4% | 05/15/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $112.00 | +30.3% | 05/14/2026 |
Unknown Analyst Argus Research | Buy | Maintained | $86.00 | +0% | 05/05/2026 |
Brandon Vazquez William Blair | Buy | Maintained | $59.00 | -31.4% | 05/01/2026 |
Suraj Kalia Oppenheimer | Hold | Reiterated | - | - | 02/13/2026 |
Next call in 10 days
Thu, Oct 29, 10:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.67
Revenue / Est. (USD)
- / 1.33B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.21B | 1.26B | 1.19B | 1.31B |
Cost of goods sold | 477.90M | 466.90M | 441.60M | 478.40M |
Cost of revenue | 477.90M | 466.90M | 441.60M | 478.40M |
Research and development expenses | 157.50M | 148.20M | 145.30M | 153.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 331.40M | 321.50M | 349.70M | 358.70M |
Operating expense | 488.90M | 469.70M | 495.00M | 511.70M |
Total operating expenses | 966.80M | 936.60M | 936.60M | 990.10M |
Operating income | 242.50M | 323.00M | 255.30M | 318.30M |
Other non operating income | 81.80M | -1.60M | -2.20M | -4.70M |
EBT including unusual items | 352.30M | 340.70M | 269.50M | 317.50M |
EBT excluding unusual items | 352.30M | 340.70M | 269.50M | 317.50M |
Income tax expense | 68.50M | 73.40M | 70.00M | 68.40M |
Effective tax rate | 19.44% | 21.54% | 25.97% | 21.54% |
Other operating expenses | - | - | - | - |
Net income | 283.80M | 267.30M | 199.50M | 249.10M |
Net profit margin | 23.47% | 21.22% | 16.74% | 19.04% |
Earnings per share | 0.61 | 0.68 | 0.56 | 0.70 |
Interest and investment income | 32.70M | 23.50M | 19.50M | 16.90M |
Interest expense | -4.70M | -4.20M | -3.10M | -3.00M |
Net interest expenses | 28.00M | 19.30M | 16.40M | 13.90M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 306.10M | 388.20M | 322.40M | 386.50M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1